Gornitzky represented the underwriters, led by Maxim Group, in the USD 11.2 million IPO of Entera Bio Ltd.
Gornitzky represented the underwriters, led by Maxim Group, in the USD 11.2 million initial public offering of shares and warrants of Entera Bio Ltd. on the NASDAQ Capital Market. Entera Bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics for use in orphan indications and other areas with significant unmet medical need.
Maxim Group LLC acted as the sole book-running manager for the offering and Joseph Gunnar & Co. acted as co-manager for the offering.
The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Nir Knoll (Associate).
